Neural stem cells (NSCs) engineered by Northwestern Medicine investigators used in combination with the HER2 inhibitor drug tucatinib improved survival in mice with HER2-positive breast cancer brain metastases, according ...
Feb 2, 2022
0
97
President Joe Biden announced a relaunch of the government's cancer "moonshot" effort in a White House ceremony Wednesday, setting a goal of cutting the US death rate from the disease by half.
Feb 2, 2022
0
9
Short bursts of radiation therapy dramatically enhanced the efficiency of targeting glioblastomas with natural nanoparticle-based immunotherapy, thus suppressing growth of the deadly tumor, inducing anti-tumor immunity and ...
Jan 31, 2022
0
135
A study led by researchers at RCSI University of Medicine and Health Sciences and the Beaumont RCSI Cancer Centre (BRCC) has revealed a potential new way to treat secondary breast cancer that has spread to the brain, using ...
Jan 28, 2022
0
60
UNC Lineberger Comprehensive Cancer Center researchers have demonstrated that a novel combination of two drugs that act as targeted inhibitors, delivered in a nanoparticle formulation, extend the survival of mice with medulloblastoma. ...
Jan 26, 2022
0
92
New guidelines for treating cancers that have spread to the brain are poised to improve care for patients and help many live longer, better lives.
Jan 26, 2022
0
6
An international team of scientists, including those at the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, has devised a tool that could help design more successful clinical trials for new ...
Dec 20, 2021
0
22
Researchers at Uppsala University have used AI to develop a new method to study brain cancer. The method is based on transplanting tumor cells from patients to fish embryos, followed by observation with AI. The method, which ...
Dec 20, 2021
0
0
In a recent study published in Nature Biomedical Engineering, a team led by researchers at Massachusetts General Hospital (MGH) has demonstrated that magnetic resonance imaging (MRI) and artificial intelligence (AI) can be ...
Dec 1, 2021
0
83
Northwestern Medicine scientists have discovered a new biomarker to identify which patients with brain tumors called glioblastomas—the most common and malignant of primary brain tumors—might benefit from immunotherapy.
Nov 29, 2021
0
73
